Docs Fear Deadly Combo of Flu, MRSA
April 26, 2008— -- One is a viral illness responsible for an estimated 35,000 deaths every year. The other is a potentially deadly superbug, a horrifying legacy of antibiotic overuse that is now resistant to almost every treatment today's doctors can throw at it.
Even on their own, infection with either influenza or methicillin-resistant Staphylococcus aureus (MRSA) can lead to a grave situation. But now, health officials are keeping an eye out for an even more harrowing threat -- simultaneous infection with both diseases. And they say that, in children at least, these cases of co-incident infection appear to be on the rise.
So far, what the U.S. Centers for Disease Control and Prevention has learned about the potential link between flu and MRSA in young patients is disturbing.
According to an official health advisory issued Jan. 30, between Oct. 1, 2006, and Sept. 30, 2007, the agency received a total of 73 reports of child deaths due to influenza. In 22 of these cases, the children were also infected with some form of the staph bug, mostly MRSA.
This compares with only three such cases of co-infection during the same period in 2005 and 2006, and just one such case identified in 2004-2005.
And on Friday, the Boston Globe reported that Massachusetts health officials have linked MRSA to two recent deaths in children from the flu, renewing concerns over such a surge.
It is not the first time that viral and bacterial infections have gone hand-in-hand, notes Dr. Jonathan C. Weissler, chief of medicine at University of Texas Southwestern University Hospitals in Dallas.
"It is well known that community-acquired staph pneumonia is much more common in patients who have influenza," he says. "This has not changed."
But when it does happen, the results can be disastrous. Infectious disease experts say spikes in this kind of co-incidence of influenza and drug-resistant bugs have happened in the past, with devastating results even for many healthy individuals.
"The association of influenza viral infection disrupting the mucosa to permit secondary bacterial infection is not new," says Dr. Jerome Klein, professor of pediatrics at Boston University School of Medicine. "This is what happened in the influenza pandemic in 1957, which was co-incident with a pandemic of multidrug resistant staphylococcal infections. Not only were the elderly and immunocompromised prone to the combination, but otherwise healthy individuals were felled with substantial morbidity and mortality."
